Below are our most recent news releases. Click on a news item to read more.
Oct 14, 2021 – MAIA Biotechnology, Inc. Announces $6.2 Million Financing to Advance Targeted Immuno-Oncology Studies
Sep 28, 2021 – MAIA Biotechnology, Inc. Announces the Appointment of Steven M. Chaouki to Its Board of Directors
Sep 15, 2021 – MAIA Biotechnology, Inc. Announces Formation of Scientific Advisory Board
Aug 17, 2021 – MAIA Biotechnology, Inc. Appoints Joseph F. McGuire as Chief Financial Officer and Provides Corporate Update
Aug 04, 2021 – MAIA Biotechnology, Inc. Announces Additions to Executive Team and Board of Directors
May 19, 2021 – MAIA Biotechnology, Inc. Raises $8.0 Million Financing to Advance Pipeline of Targeted Immuno-Oncology Studies
Mar 25, 2021 – MAIA Biotechnology to Present at Upcoming Investor Conferences
Feb 02, 2021 – MAIA Biotechnology, Inc. Announces Clinical Supply Agreement with Regeneron for Phase 1/2 Clinical Trial Evaluating THIO in Sequential Administration with Libtayo® (cemiplimab) in Advanced Non-Small Cell Lung Cancer
Jul 07, 2020 – MAIA Biotechnology, Inc. Announces Publication in Cancer Cell of Encouraging Data on the Immunogenic Effects of Its Flagship Product Candidate THIO
Currently, there are no future events scheduled for MAIA. Please check back soon.
Mar 29-Apr 2, 2021 – MedInvest Spring 2021 Oncology Investor Conference
Mar 23-25, 2021 – Keiretsu Midwest Angel Forum